← DOT non-FAA Federal Register rules

Conforming Amendments and Technical Corrections to Department Rules Implementing the Transportation Industry Drug Testing Program

pipeline-safety · Pipeline and Hazardous Materials Safety Administration · Published 2019-04-23 · Effective 2019-04-23 · 84 FR 16770

Document

Document number
2019-06986
Federal Register citation
84 FR 16770
CFR reference
14 CFR 120
Type
Rule
Action
Final rule.
Category
pipeline-safety
Sub-agency
Pipeline and Hazardous Materials Safety Administration
Publication date
2019-04-23
Effective date
2019-04-23

Abstract

This final rule makes minor technical corrections to the OST, FAA, FTA, and PHMSA regulations governing drug testing for safety- sensitive employees to ensure consistency with the recent amendments made to the Department of Transportation's regulation, "Procedures for Transportation Workplace Drug and Alcohol Testing Programs," which added requirements to test for oxycodone, oxymorphone, hydrocodone, and hydromorphone to DOT-regulated drug testing programs. The changes to the Department's regulation make it necessary to refer to these substances, as well as the previously covered drugs morphine, 6- acetylmorphine, and codeine, by the more inclusive term "opioids," rather than "opiates." This rule amends the term in the FAA, FTA, and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and with the Mandatory Guidelines for Federal Workplace Drug Testing Programs. In addition, this rule makes a conforming amendment to include the term "opioids" in the wording of the Department's annual information collection requirement and clarifications to section 40.26 and Appendix H regarding the requirement for employers to follow the Department's instructions for the annual information collection.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown